Herbert Virgin, EVP, Research & CSO at Vir Biotechnology, Inc. (VIR), sold 1,375 shares at $33.75 ($46K) on 2021-10-05, disclosed to the SEC on 2021-10-06.
Scheduled sale ($46k) by EVP, Research & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VIR | SELL | 2022-02-09 | $47K | — | Filing → |
| VIR | SELL | 2022-01-26 | $45K | — | Filing → |
| VIR | SELL | 2022-01-13 | $48K | — | Filing → |